Regulation of nuclear pre-mRNA domain-containing protein 2 (RPRD2)

Regulation of nuclear pre-mRNA domain-containing protein 2 (RPRD2) is a protein in humans encoded by the RPRD2 gene. It contains a CTD-interacting domain (CID) and is known to co-purify with the RNA polymerase II complex. RPRD2 is predicted to enable RNA polymerase II complex binding and to play a role in mRNA 3'-end processing as well as regulation of gene expression via its involvement in transcription. Current evidence does not indicate it is a direct therapeutic target, nor are there known interacting drugs, mechanisms of drug action, or biomarker associations. It is primarily classified as a regulator of basic gene expression machinery and not linked to specific therapeutic areas or diseases[1][2][3][5][8][10]. **Clarifications about correctness and target status:** - The canonical full name is "Regulation of nuclear pre-mRNA domain-containing protein 2," with RPRD2 as the accepted abbreviation[2][5][6][7][8]. - This protein is not generally considered a receptor, enzyme, transporter, or a direct therapeutic target; rather, it functions as a transcription regulator, making **is_target: false** and **is_incorrect: true** if used as a receptor or drug target name in most pharmaceutical contexts. - There is no evidence from current sources of common drug interactions, known utility as a biomarker, or evident disease role, nor notable safety concerns. - If your use case was to find a classical drug target (receptor, enzyme, transporter, etc.), this is likely not correct.

Other names

KIAA0460P15RS